富士达(835640) - 2024 Q3 - 季度财报

Financial Performance - Operating revenue for the first nine months of 2024 was ¥558,665,461.56, a decrease of 15.74% year-over-year [5]. - Net profit attributable to shareholders for the first nine months of 2024 was ¥35,992,194.25, down 69.57% from the previous year [5]. - The company reported a net profit of ¥2,348,224.59 for Q3 2024, a decline of 91.63% compared to Q3 2023 [6]. - The weighted average return on equity based on net profit attributable to shareholders was 4.22% for the first nine months of 2024, down from 15.03% in the previous year [5]. - The company experienced a 67.72% decline in operating profit to ¥42,997,375.61, attributed to reduced demand in the defense sector and increased R&D expenses [9]. - Total revenue decreased by 67.73% to ¥42,936,211.57, primarily due to a decline in operating profit [10]. - Net profit fell by 64.65% to ¥44,061,960.54, attributed to the decrease in total profit [10]. - The company's operating revenue for the first nine months of 2024 was approximately ¥549.94 million, a decrease of 16% compared to ¥654.53 million in the same period of 2023 [30]. - The net profit for the first nine months of 2024 was approximately ¥44.06 million, down from ¥124.64 million in the same period of 2023, representing a decline of 64% [30]. - The company's operating profit for the first nine months of 2024 was approximately ¥42.99 million, a significant decrease from ¥133.19 million in the same period of 2023 [30]. - The total comprehensive income for the first nine months of 2024 was approximately ¥44.05 million, compared to ¥124.85 million in the same period of 2023, indicating a decline of 64.7% [30]. - The company's total profit for the first nine months of 2024 was approximately ¥32.54 million, down from ¥124.51 million in the same period of 2023, representing a decline of 73.9% [31]. Cash Flow - Cash flow from operating activities improved to ¥1,675,822.64, a significant increase of 117.90% compared to the same period last year [5]. - Operating cash flow increased by 117.90% to ¥1,675,822.64, supported by improved management of accounts receivable [10]. - Financing cash flow decreased by 198.79% to -¥73,077,229.93, mainly due to reduced cash inflow from borrowings compared to the previous year [10]. - Net cash flow from operating activities improved to CNY 1,675,822.64, compared to a negative CNY 9,363,159.62 in the previous year [34]. - Cash inflow from financing activities was CNY 81,550,907.17, down 36.0% from CNY 127,266,822.07 in the previous year [34]. - Net cash flow from financing activities showed a larger outflow of CNY 73,077,229.93 compared to CNY 24,457,635.57 in the same period last year [34]. - Total cash outflow for operating activities was CNY 407,531,575.39, a decrease from CNY 497,055,506.60 year-over-year [35]. Assets and Liabilities - Total assets as of September 30, 2024, reached ¥1,389,682,636.89, an increase of 1.00% compared to the end of 2023 [4]. - Cash and cash equivalents decreased by 48.08% to ¥120,648,216.97 due to the concentration of payable notes [8]. - Accounts receivable increased by 42.54% to ¥625,797,295.64, primarily due to the growth in defense sector receivables [8]. - The total liabilities rose to ¥503,154,770.07 from ¥485,162,525.03, reflecting an increase of approximately 3.8% [24]. - The company's equity attributable to shareholders decreased to ¥852,957,559.99 from ¥861,167,283.98, a decline of about 1.5% [24]. - The company's total assets amounted to ¥1,389,682,636.89, an increase from ¥1,375,964,724.55 at the end of 2023 [22]. - The company's cash and cash equivalents decreased to ¥120,648,216.97 from ¥232,387,851.71, representing a decline of approximately 48.2% [22]. - Accounts receivable increased significantly to ¥625,797,295.64, up from ¥439,040,454.07, indicating a growth of about 42.5% [22]. - The company's long-term investments in equity decreased slightly to ¥13,268,656.35 from ¥13,440,216.98 [22]. - Total assets decreased to CNY 1,329,679,259.21 from CNY 1,340,737,237.10, a reduction of 0.8% [28]. - Total liabilities slightly decreased to CNY 503,285,711.76 from CNY 505,115,287.66, a decline of 0.4% [27]. - The company’s total equity decreased to CNY 826,393,547.45 from CNY 835,621,949.44, a decline of 1.4% [28]. Research and Development - Research and development expenses increased to CNY 63,439,040.13, up 21.0% from CNY 52,419,219.84 in the previous year [29]. - Research and development expenses increased to approximately ¥67.39 million in the first nine months of 2024, up from ¥55.85 million in the same period of 2023, reflecting a growth of 20.5% [31]. Other Income and Expenses - Other income increased by 119.51% to ¥8,857,800.60, mainly due to higher government subsidies received compared to the previous year [9]. - The company recorded other income of approximately ¥8.56 million in the first nine months of 2024, an increase from ¥3.92 million in the same period of 2023 [31]. - The company reported a credit impairment loss of approximately ¥19.76 million in the first nine months of 2024, compared to a loss of ¥21.42 million in the same period of 2023 [31].